Providers are growing increasingly concerned about rising pharmaceutical and supply chain costs in 2025 ... Increased demand for specialty and personalized drugs will drive a portion of increased ...

Health supply chain costs and pharmaceutical ... services company Vizient. Pharmacy spend will rise 3.8%, driven in part by increased demand for specialty medications. AbbVie’s autoimmune ...

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

The Prescription Drug Affordability Act would aim to stop pharmacy benefit managers, or PBMs, from “exploiting loopholes” to ...

Biosimilars have also made inroads among generic suppliers. But development is lengthy and expensive. McKinsey estimates that it costs $100 to $300 million to develop a biosimilar and that it takes ...

Tractor Supply Company (NASDAQ: TSCO), the largest rural lifestyle retailer in the United States (the "Company"), today ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

Mark Cuban is best known for business and basketball, but lately his passion has been shaking up the pharmaceutical world by ...

The bill's supporters framed it as part of the solution to addressing both high drug prices and slowing the pace of pharmacy closures in Iowa.

CHICAGO—On the heels of his 2025 State of the State budget address, Governor Pritzker focused on one of his top legislative ...